Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis

Multiple Sclerosis

Volumn 21, Issue 7, 2015, Pages 935-944

  Bester, M ^b,c   Jensen, J H ^a   Babb, J S ^b   Tabesh, A ^a   Miles, L ^b   Herbert, J ^b   Grossman, R I ^b   Inglese, M ^b,d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

cognitive impairment; diffusion; gray matter; kurtosis; MRI; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; NATALIZUMAB;

ADULT; ARTICLE; BRAIN INJURY; BRAIN SIZE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIFFUSION KURTOSIS IMAGING; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; FEMALE; FRACTIONAL ANISOTROPY; GRAY MATTER; HUMAN; MALE; MENTAL PERFORMANCE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; WHITE MATTER LESION; BRAIN; COGNITION DISORDERS; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; MIDDLE AGED; PATHOLOGY; PROCEDURES; PSYCHOLOGY; YOUNG ADULT;

ADULT; BRAIN; COGNITION DISORDERS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GRAY MATTER; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPSYCHOLOGICAL TESTS; YOUNG ADULT;

EID: 84930408353     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514556295     Document Type: Article

References (36)

1. Riccitelli G, Rocca MA, Pagani E, et al. Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype. Hum Brain Mapp. 2011; 32: 1535-1543
2. Geurts JJ, Pouwels PJ, Uitdehaag BM, et al. Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversion-recovery MR imaging. Radiology. 2005; 236: 254-260
3. Poonawalla A, Datta S, Wolinsky J, et al. Is 3D MPRAGE better than the combination DIR/PSIR for cortical lesion detection at 3T MRI?. Mult Scler Relat Disord. 2014; 3: 253-257
4. Calabrese M, Rinaldi F, Seppi D, et al. Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: A 3-year longitudinal study. Radiology. 2011; 261: 891-898
5. Chen JT, Easley K, Schneider C, et al. Clinically feasible MTR is sensitive to cortical demyelination in MS. Neurology. 2013; 80: 246-252
6. Jensen JH, Helpern JA, Ramani A, et al. Diffusional kurtosis imaging: The quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med. 2005; 53: 1432-1440
7. Steven AJ, Zhuo J, Melhem ER. Diffusion kurtosis imaging: An emerging technique for evaluating the microstructural environment of the brain. AJR Am J Roentgenol. 2014; 202: W26 - W33
8. Zhuo J, Xu S, Proctor JL, et al. Diffusion kurtosis as an in vivo imaging marker for reactive astrogliosis in traumatic brain injury. Neuroimage. 2012; 59: 467-477
9. Van Cauter SS, Veraart JJ, Sijbers JJ, et al. Gliomas: Diffusion kurtosis MR imaging in grading. Radiology. 2012; 263: 492-501
10. Grossman EJ, Jensen JH, Babb JS, et al. Cognitive impairment in mild traumatic brain injury: A longitudinal diffusional kurtosis and perfusion imaging study. AJNR Am J Neuroradiol. 2013; 34: 951-957
11. Gong NJ, Wong CS, Chan CC, et al. Correlations between microstructural alterations and severity of cognitive deficiency in Alzheimer's disease and mild cognitive impairment: A diffusional kurtosis imaging study. Magn Reson Imaging. 2013; 31: 688-694
12. Raz E, Bester M, Sigmund EE, et al. A better characterization of spinal cord damage in multiple sclerosis: A diffusional kurtosis imaging study. AJNR Am J Neuroradiol. 2013; 34: 1846-1852
13. Falangola MF, Jensen JH, Babb JS, et al. Age-related non-Gaussian diffusion patterns in the prefrontal brain. J Magn Reson Imaging. 2008; 28: 1345-1350
14. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69: 292-302
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology. 1983; 33: 1444-1452
16. Lezak MD Neuropsychological assessment. New York, USA: Oxford University Press; 1995 :
17. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 2002; 17: 479-489
18. Agosta F, Rovaris M, Pagani E, et al. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain. 2006; 129: 2620-2627
19. Jensen JH, Helpern JA. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed. 2010; 23: 698-710
20. Filippi M, Preziosa P, Pagani E, et al. Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis. Mult Scler. 2013; 19: 418-426
21. Poonawalla AH, Hasan KM, Gupta RK, et al. Diffusion-tensor MR imaging of cortical lesions in multiple sclerosis: Initial findings. Radiology. 2008; 246: 880-886
22. Peterson JW, Bö L, Mörk S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001; 50: 389-400
23. Färber K, Kettenmann H. Physiology of microglial cells. Brain Res Brain Res Rev. 2005; 48: 133-143
24. McKinstry RC, Mathur A, Miller JH, et al. Radial organization of developing preterm human cerebral cortex revealed by non-invasive water diffusion anisotropy MRI. Cereb Cortex. 2002; 12: 1237-1243
25. Geurts JJG, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol. 2008; 7: 841-851
26. Magliozzi R, Howell O, Vora A, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007; 130 (Pt 4). 1089-1104
27. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005; 128: 2705-2712
28. Bø L, Geurts JJG, van der Valk P, et al. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol. 2007; 64: 76-80
29. De Stefano N, Matthews PM, Filippi M, et al. Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability. Neurology. 2003; 60: 1157-1162
30. Bodini B, Khaleeli Z, Cercignani M, et al. Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: An in vivo study with TBSS and VBM. Hum Brain Mapp. 2009; 30: 2852-2861
31. Yang AW, Jensen JH, Hu CC, et al. Effect of cerebral spinal fluid suppression for diffusional kurtosis imaging. J Magn Reson Imaging. 2013; 37: 365-371
32. Calabrese M, Filippi M, Rovaris M, et al. Evidence for relative cortical sparing in benign multiple sclerosis: A longitudinal magnetic resonance imaging study. Mult Scler. 2009; 15: 36-41
33. Rao SM, Leo GJ, Bernardin L, et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991; 41: 685-691
34. Zwibel HL, Smrtka J. Improving quality of life in multiple sclerosis: An unmet need. Am J Manag Care. 2011; 17: S139 - S145
35. Filippi M, Rocca MA, Benedict RHB, et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology. 2010; 75: 2121-2128
36. Inglese M, Adhya S, Johnson G, et al. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab. 2007; 28: 164-171